Studies show that GLP-1 receptor agonists have significant potential for treating glaucoma, diabetic retinopathy and other ...

A review published in BMC Ophthalmology has found that GLP-1 receptor agonists may help protect against ocular hypertension, glaucoma, late-stage diabetic retinopathy, and dry age-related ...

(RTTNews) - Shares of Ocular Therapeutics, Inc. (OCUL), are up 23% in pre-market trading today, reflecting investor enthusiasm around the company's late-stage pipeline in retinal and glaucoma programs ...

Dr Shibal Bhartiya explains how early diagnosis, digital screening, and treatment advances are changing glaucoma care in ...

A glaucoma diagnosis can feel alarming, especially knowing that optic nerve damage cannot be reversed. Rachel Simpson, MD, a glaucoma specialist at the John A. Moran Eye Center at University of Utah, ...

Glaucoma is often called the “silent thief of sight” because the disease can damage vision for years before people notice ...

In a first of its kind study, Mount Sinai researchers are using optimal coherence tomography (OCT) angiography to look at the earliest stages of glaucoma and identify characteristic patterns of ...

Cases of glaucoma, a common eye condition that can cause blindness if left untreated, are projected to rise by 60% in the UK by 2060. Researchers said the increase is a “demographic timebomb” that ...